All Releases
 |
Johnson & Johnson Announces Definitive Agreement to Acquire Micrus Endovascular
Jul 12, 2010
|
16.4 KB |
|
| |
New Brunswick, N.J. and San Jose, Calif. (July 12, 2010) - Johnson & Johnson (NYSE: JNJ) and Micrus Endovascular Corporation (NASDAQ: MEND), a global developer and manufacturer of minimally invasive devices to address hemorrhagic and ischemic stroke, today announced a definitive agreement whereby Micrus Endovascular will be acquired in a cas...
|
|
Micrus Endovascular Receives Approval to Market DeltaPaq and DeltaPlush Microcoils in Japan
Jun 17, 2010
|
13.6 KB |
|
| |
SAN JOSE, Calif., Jun 17, 2010 (BUSINESS WIRE) -- Micrus Endovascular Corporation (NASDAQ:MEND) today announced
receipt of Shonin approval from the Ministry of Health, Labour and
Welfare to market in Japan its novel bare platinum and Cerecyte(R)
DeltaPaq(TM) filling and DeltaPlush(TM) finishing microcoils for the treatment
...
|
|
Micrus Endovascular to Present at June Investment Conferences
Jun 3, 2010
|
11.9 KB |
|
| |
SAN JOSE, Calif., Jun 03, 2010 (BUSINESS WIRE) -- Micrus Endovascular Corporation (NASDAQ:MEND) today announced
that senior management will present at three investment conferences in
June:
Robert Stern, President and Chief Operating Officer, will present at Noble
Financial's Sixth Annual Equity Conferenc...
|
|
Landmark Randomized Trial Shows Exceptional Clinical Outcomes for Micrus Endovascular Microcoils
May 21, 2010
|
16.7 KB |
|
| |
SAN JOSE, Calif., May 21, 2010 (BUSINESS WIRE) -- Micrus Endovascular Corporation (NASDAQ:MEND) announces that
preliminary six-month follow-up data from the Cerecyte Coil Trial (CCT)
show exceptionally strong clinical outcomes for both Micrus Endovascular
Cerecyte(R) and bare platinum microcoils in the treatment of
c...
|
|
Micrus Endovascular Fiscal Fourth Quarter Neurovascular Revenues Increase 24% to $25.6 Million
May 6, 2010
|
28.9 KB |
|
| |
SAN JOSE, Calif., May 06, 2010 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq: MEND) today reported
financial results for the three and 12 months ended March 31, 2010 and
introduced fiscal 2011 financial guidance.
Highlights for the fiscal 2010 fourth quarter and full year include the
following (all comparisons ...
|
|
Micrus Endovascular to Hold Fiscal 2010 Fourth Quarter and Full Year Conference Call on May 6
Apr 29, 2010
|
11.8 KB |
|
| |
SAN JOSE, Calif., Apr 29, 2010 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq: MEND) today announced
that it will release financial results for the quarter and full year
ended March 31, 2010 before market open on Thursday, May 6, 2010.
Micrus' management will host an investment community conference call at
...
|
|
Micrus Endovascular Reports Fiscal Third Quarter Revenues of $22.8 Million and Diluted EPS of $0.20
Feb 4, 2010
|
28.7 KB |
|
| |
SAN JOSE, Calif., Feb 04, 2010 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq: MEND) today reported
financial results for the three and nine months ended December 31, 2009
and raised fiscal 2010 revenue guidance.
Highlights for the third quarter and first nine months of fiscal 2010
include the following (all com...
|
|
Micrus Endovascular to Hold Fiscal 2010 Third Quarter Conference Call on February 4
Jan 28, 2010
|
11.8 KB |
|
| |
SAN JOSE, Calif., Jan 28, 2010 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq: MEND) today announced
that it will release financial results for the quarter ended December
31, 2009 before market open on Thursday, February 4, 2010. Micrus'
management will host an investment community conference call at 10:30
...
|
|
Micrus Endovascular to Present at January Investment Conferences
Jan 5, 2010
|
11.8 KB |
|
| |
SAN JOSE, Calif., Jan 05, 2010 (BUSINESS WIRE) -- Micrus Endovascular Corporation (NASDAQ:MEND) today announced
that senior management will present at two investment conferences in
January:
Robert Stern, President and Chief Operating Officer, will present at
the OneMedForum 2010 Finance Conference on Tuesday, Ja...
|
|
Micrus Endovascular to Present at the Piper Jaffray 21st Annual Health Care Conference
Nov 24, 2009
|
11.5 KB |
|
| |
SAN JOSE, Calif., Nov 24, 2009 (BUSINESS WIRE) -- Micrus Endovascular Corporation (NASDAQ:MEND) today announced
that Robert Stern, President and Chief Operating Officer, will present
at the Piper Jaffray 21st Annual Health Care Conference on
Wednesday, December 2, 2009 at 10:30 a.m. Eastern time (7:30 a.m.
Pacific ti...
|
|
Micrus Endovascular Reports Fiscal Second Quarter Revenues of $21.5 Million and Diluted EPS of $0.22
Nov 5, 2009
|
27.6 KB |
|
| |
SAN JOSE, Calif., Nov 05, 2009 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq: MEND) today reported
financial results for the three and six months ended September 30, 2009
and increased fiscal 2010 revenue guidance.
Highlights for the second quarter and first six months of fiscal 2010
include the following (comp...
|
|
Micrus Endovascular to Present at the Canaccord Cardiovascular Conference
Nov 4, 2009
|
11.4 KB |
|
| |
SAN JOSE, Calif., Nov 04, 2009 (BUSINESS WIRE) -- Micrus Endovascular Corporation (NASDAQ: MEND) today announced
that Robert Stern, President and Chief Operating Officer, will present
at the third annual Canaccord Cardiovascular Conference on Tuesday,
November 10, 2009, at 4:00 p.m. Pacific time (7:00 p.m. Eastern time) at
...
|
|
Micrus Endovascular to Hold Fiscal 2010 Second Quarter Conference Call on November 5
Oct 29, 2009
|
11.7 KB |
|
| |
SAN JOSE, Calif., Oct 29, 2009 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq: MEND) today announced
that it will release financial results for the quarter ended September
30, 2009 before market open on Thursday, November 5, 2009. Micrus'
management will host an investment community conference call at 10:30
...
|
|
Micrus Endovascular to Present at September Investment Conferences
Sep 3, 2009
|
11.6 KB |
|
| |
SAN JOSE, Calif., Sep 03, 2009 (BUSINESS WIRE) -- Micrus Endovascular Corporation (NASDAQ: MEND) today announced
that senior management will present at two investment conferences in
September:
Gordon Sangster, Chief Financial Officer, will present at the Baird
Health Care Conference on Thursday, September 10, 20...
|
|
Micrus Endovascular Signs Licensing and Development Agreement for Flow Diversion Technology
Aug 24, 2009
|
15.5 KB |
|
| |
SAN JOSE, Calif., Aug 24, 2009 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq: MEND) and privately held
Flexible Stenting Solutions Inc. of Eatontown, N.J., today announced the
signing of an exclusive agreement to jointly develop a flow diversion
technology for neurovascular indications using both Micrus and Flex...
|
|
Micrus Endovascular Reports Fiscal First Quarter EPS of $0.14 and Record Quarterly Revenues of $21.2 Million
Aug 6, 2009
|
24.6 KB |
|
| |
SAN JOSE, Calif., Aug 06, 2009 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq: MEND) today reported
financial results for the three months ended June 30, 2009 and raised
fiscal 2010 revenue guidance.
Highlights for the first quarter of fiscal 2010 include the following
(all revenue comparisons are with the first...
|
|
Micrus Endovascular to Hold Fiscal 2010 First Quarter Conference Call on August 6
Jul 30, 2009
|
11.6 KB |
|
| |
SAN JOSE, Calif., Jul 30, 2009 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq: MEND) today announced
that it will release financial results for the quarter ended June 30,
2009 before market open on Thursday, August 6, 2009. Micrus' management
will host an investment community conference call at 10:30 a.m. Eastern...
|
|
Micrus Endovascular Announces Positive DeltaPaq Microcoil Study Results
Jul 23, 2009
|
14.0 KB |
|
| |
SAN JOSE, Calif., Jul 23, 2009 (BUSINESS WIRE) -- Micrus Endovascular Corporation (NASDAQ:MEND) today announced
that study results presented recently at the 10th Congress of the World
Federation of Interventional and Therapeutic Neuroradiology (WFITN)
demonstrated that the DeltaPaq(TM) microcoil's proprietary design appears ...
|
|
Micrus Endovascular to Present at June Investment Conferences
Jun 3, 2009
|
11.3 KB |
|
| |
SAN JOSE, Calif., Jun 03, 2009 (BUSINESS WIRE) -- Micrus Endovascular Corporation (NASDAQ:MEND) today announced
that Gordon Sangster, Chief Financial Officer, will make a presentation
at two investment conferences in June:
Noble Financial Fifth Annual Emerging Growth Conference
Tuesday, June 9th at 11:35 a.m. Eastern time...
|
|
Micrus Endovascular Reports Fourth Quarter Diluted EPS of $0.04
May 7, 2009
|
25.8 KB |
|
| |
SAN JOSE, Calif., May 07, 2009 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq:MEND) today reported
financial results for the three and 12 months ended March 31, 2009, and
introduced fiscal 2010 financial guidance.
Total revenues for fiscal 2009 were $78.2 million, reflecting an
increase of 13% from fiscal 2008 a...
|
|
|
